Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous LNG/EE Regimen for Ovulation Inhibition
NCT00254189Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of avatrombopag, ethinyl estradiol in contraception, sponsored by Pfizer. Started Dec 2002; status: completed.
02
Drugs
avatrombopagethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00254189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254189.